Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised contr... by Lieverse, Relinde I Y, Van Limbergen, Evert J, Oberije, Cary J G, Troost, Esther G C, Hadrup, Sine R, Dingemans, Anne-Marie C, Hendriks, Lizza E L, Eckert, Franziska, Hiley, Crispin, Dooms, Christophe, Lievens, Yolande, de Jong, Monique C, Bussink, Johan, Geets, Xavier, Valentini, Vincenzo, Elia, Giuliano, Neri, Dario, Billiet, Charlotte, Abdollahi, Amir, Pasquier, David, Boisselier, Pierre, Yaromina, Ala, De Ruysscher, Dirk, Dubois, Ludwig J, Lambin, Philippe

Get full text

Radiomics: from qualitative to quantitative imaging by Rogers, William, Thulasi Seetha, Sithin, Refaee, Turkey A G, Lieverse, Relinde I Y, Granzier, Renée W Y, Ibrahim, Abdalla, Keek, Simon A, Sanduleanu, Sebastian, Primakov, Sergey P, Beuque, Manon P L, Marcus, Damiënne, van der Wiel, Alexander M A, Zerka, Fadila, Oberije, Cary J G, van Timmeren, Janita E, Woodruff, Henry C, Lambin, Philippe

Get full text

Charged Particle and Conventional Radiotherapy: Current Implications as Partner for Immunotherapy by Marcus, Damiënne, Lieverse, Relinde I Y, Klein, Carmen, Abdollahi, Amir, Lambin, Philippe, Dubois, Ludwig J, Yaromina, Ala

Get full text

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer by Lieverse, Relinde I. Y., Marcus, Damiënne, Wiel, Alexander M. A., Van Limbergen, Evert J., Theys, Jan, Yaromina, Ala, Lambin, Philippe, Dubois, Ludwig J.

Get full text

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy by Olivo Pimentel, Veronica, Marcus, Damiënne, van der Wiel, Alexander MA, Lieuwes, Natasja G, Biemans, Rianne, Lieverse, Relinde IY, Neri, Dario, Theys, Jan, Yaromina, Ala, Dubois, Ludwig J, Lambin, Philippe

Get full text

Improving shared decision making for lung cancer treatment by developing and validating an open-source web based patient decision aid for stage I-II non-small cell lung cancer by Halilaj, Iva, Ankolekar, Anshu, Lenaers, Anouk, Chatterjee, Avishek, Oberije, Cary J G, Eppings, Lisanne, Smit, Hans J M, Hendriks, Lizza E L, Jochems, Arthur, Lieverse, Relinde I Y, van Timmeren, Janita E, Wind, Anke, Lambin, Philippe

Get full text

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy by Lambin, Philippe, Lieverse, Relinde I.Y., Eckert, Franziska, Marcus, Damiënne, Oberije, Cary, van der Wiel, Alexander M.A., Guha, Chandan, Dubois, Ludwig J., Deasy, Joseph O.

Get full text

Hypoxia PET Imaging with [18F]-HX4-A Promising Next-Generation Tracer by Sanduleanu, Sebastian, Wiel, Alexander M A van der, Lieverse, Relinde I Y, Marcus, Damiënne, Ibrahim, Abdalla, Primakov, Sergey, Wu, Guangyao, Theys, Jan, Yaromina, Ala, Dubois, Ludwig J, Lambin, Philippe

Get full text

Stereotactic ablative body radiotherapy versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial by Lieverse, Relinde I. Y, Van Limbergen, Evert J, Oberije, Cary J. G, Troost, Esther G. C, Hadrup, Sine R, Dingemans, Anne-Marie C, Hendriks, Lizza E. L, Eckert, Franziska, Hiley, Crispin, Dooms, Christophe, Lievens, Yolande, de Jong, Monique C, Bussink, Johan, Geets, Xavier, Valentini, Vincenzo, Elia, Giuliano, Neri, Dario, Billiet, Charlotte, Abdollahi, Amir, Pasquier, David, Boisselier, Pierre, Yaromina, Ala, De Ruysscher, Dirk, Dubois, Ludwig J, Lambin, Philippe

Get full text